Featured Research

from universities, journals, and other organizations

UCSF Study Shows For The First Time That A Drug May Reduce Risk Of Hip Fractures By More Than Half In Women Who Have Never Had A Spine Fracture

Date:
September 16, 1998
Source:
University Of California, San Francisco
Summary:
An osteoporosis drug can reduce the risk of hip fractures by 56 percent among women who have never suffered a spinal fracture, according to a University of California San Francisco researcher who announced new results from the landmark Fracture Intervention Trial (FIT) today (Monday, September 14) at an annual scientific meeting.

BERLIN, GERMANY-- An osteoporosis drug can reduce the risk of hip fractures by 56 percent among women who have never suffered a spinal fracture, according to a University of California San Francisco researcher who announced new results from the landmark Fracture Intervention Trial (FIT) today (Monday, September 14) at an annual scientific meeting.

"These results are dramatic," said Dennis Black, PhD, UCSF professor of medicine and epidemiology, lead author of the study, who will present his findings at the European Congress on Osteoporosis. "No other therapy has been shown to work in such a wide spectrum of women with osteoporosis to reduce the most devastating of fractures--those that occur at the hip."

Hip fractures, the most debilitating, increase a women's risk of requiring nursing home care by 25 percent. Half of the women who suffer a hip fracture are disabled, many permanently, Black said.

The new findings from the FIT study, a 6,000 patient trial, show that the osteoporosis drug, called alendronate, also reduced the likelihood of painful spine fractures by 49 percent in women who have never had a spine fracture. Among women in the study who did not have osteoporosis, fractures were less common. However, this group did achieve increases in bone mineral density.

In a previous arm of FIT, which only included osteoporatic women who had already suffered a spinal fracture, alendronate reduced the risk of hip fractures by 51 percent and the risk of spine fractures by 47 percent.

Other key findings of the FIT analysis to be presented during the European World Congress include:

  • Patients with fractures have an increased risk of death that is associated with the type of fracture a woman experiences. Hip fractures were shown to increase the relative risk of death 6.7 times and painful spine fractures 8.6 times.
  • The prevalence of "silent" spine fractures, defined as those that increase a woman's risk of subsequent fractures but are only detected by X-ray, increased the incidence of future hospitalization by 29 percent and the risk of death by over one and a half times. These findings could not be explained by other conditions the women may have had, nor by their bone mineral density upon entering FIT.
"These new data from FIT shed light on the serious consequences associated with fractures and provide further evidence of the importance of preventing fractures," said Steven Cummings, MD, UCSF professor of medicine and epidemiology and lead author of the study.

Another important finding from FIT, reported by Cummings, was that among the small percentage of women who did not gain bone density in the first year of treatment with alendronate, almost all gained bone density in the second year. In clinical trials, 96 percent of women receiving alendronate increased bone mineral density over three years.

"These results show that treatment with alendronate should be continued regardless of change in bone density during the first year," said Cummings. "For the few women who do not have increases in bone mineral density during the first year, almost all will achieve significant gains in bone mineral density in the second year."

An analysis of the safety data from FIT showed that alendronate is well tolerated. Upper gastrointestinal (GI) disease is very common among older women, and the incidence of GI disease among postmenopausal women in FIT was the same regardless of whether they received alendronate or placebo. This was true even among women at the highest risk for GI problems, including those age 75 or older, with a history of upper GI disease, or those who used aspirin or non-steroidal anti-inflammatory drugs (NSAIDs), medicines often associated with upper GI disease.

"The findings are significant because they reveal that, even in women at high risk for upper GI problems, treatment with alendronate did not increase the risk of developing GI side effects," said Douglas Bauer, MD, UCSF assistant professor of medicine, epidemiology and biostatistics. "The study also found that older women frequently have upper GI symptoms, especially indigestion, and that physicians and their patients may often incorrectly assume that these common upper GI symptoms are related to their medicine."

FIT is a collaborative effort of the University of California San Francisco and 11 other academic centers. The initial phase included 2,027 postmenopausal women between the ages of 55 and 82 who had osteoporosis and previous spine fractures, as detected by X-ray. The second phase of FIT included 4,432 women with thin bones but no previous spine fractures.

More than 200 million women worldwide suffer from osteoporosis, a disease in which bone mass progressively decreases, thus increasing fracture risk. Approximately four in 10 women in the United States age 50 or older will suffer an osteoporosis-related fracture. In the United States, osteoporosis results in 1.5 million fractures each year with approximately 250,000 of these hip fractures and costs about $14 billion annually.

Alendronate, which is available as FOSAMAX in 72 countries including the United States, was developed by Merck & Co. Inc., USA which operates in many countries as Merck Sharp & Dohme.


Story Source:

The above story is based on materials provided by University Of California, San Francisco. Note: Materials may be edited for content and length.


Cite This Page:

University Of California, San Francisco. "UCSF Study Shows For The First Time That A Drug May Reduce Risk Of Hip Fractures By More Than Half In Women Who Have Never Had A Spine Fracture." ScienceDaily. ScienceDaily, 16 September 1998. <www.sciencedaily.com/releases/1998/09/980916073608.htm>.
University Of California, San Francisco. (1998, September 16). UCSF Study Shows For The First Time That A Drug May Reduce Risk Of Hip Fractures By More Than Half In Women Who Have Never Had A Spine Fracture. ScienceDaily. Retrieved July 29, 2014 from www.sciencedaily.com/releases/1998/09/980916073608.htm
University Of California, San Francisco. "UCSF Study Shows For The First Time That A Drug May Reduce Risk Of Hip Fractures By More Than Half In Women Who Have Never Had A Spine Fracture." ScienceDaily. www.sciencedaily.com/releases/1998/09/980916073608.htm (accessed July 29, 2014).

Share This




More Health & Medicine News

Tuesday, July 29, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Deadly Ebola Virus Threatens West Africa

Deadly Ebola Virus Threatens West Africa

AP (July 28, 2014) West African nations and international health organizations are working to contain the largest Ebola outbreak in history. It's one of the deadliest diseases known to man, but the CDC says it's unlikely to spread in the U.S. (July 28) Video provided by AP
Powered by NewsLook.com
$15B Deal on Vets' Health Care Reached

$15B Deal on Vets' Health Care Reached

AP (July 28, 2014) A bipartisan deal to improve veterans health care would authorize at least $15 billion in emergency spending to fix a veterans program scandalized by long patient wait times and falsified records. (July 28) Video provided by AP
Powered by NewsLook.com
Two Americans Contract Ebola in Liberia

Two Americans Contract Ebola in Liberia

Reuters - US Online Video (July 28, 2014) Two American aid workers in Liberia test positive for Ebola while working to combat the deadliest outbreak of the virus ever. Linda So reports. Video provided by Reuters
Powered by NewsLook.com
Traditional African Dishes Teach Healthy Eating

Traditional African Dishes Teach Healthy Eating

AP (July 28, 2014) Classes are being offered nationwide to encourage African Americans to learn about cooking fresh foods based on traditional African cuisine. The program is trying to combat obesity, heart disease and other ailments often linked to diet. (July 28) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins